Target intelligence / Profile preview

Multiple extracellular matrix components and immune cells in cardiac tissue

Molecular classification
Extracellular matrix protein, Cell surface protein, Cytokine, Chemokine, Other
01

Overview

Multiple extracellular matrix (ECM) components and immune cells in cardiac tissue constitute the cardiac microenvironment, a dynamic system essential for maintaining heart structure and function. The ECM, composed of proteins like collagen, elastin, and fibronectin, provides mechanical support and acts as a reservoir for signaling molecules, while immune cells, including resident macrophages and infiltrating lymphocytes, monitor tissue integrity and respond to injury (Frangogiannis, 2019, Circulation Research). In cardiovascular diseases such as myocardial infarction and heart failure, this system undergoes significant dysregulation, characterized by excessive collagen deposition (fibrosis) and chronic inflammation (Swirski & Nahrendorf, 2018, Nature Reviews Immunology). Therapeutic interventions targeting this environment seek to modulate immune cell phenotypes and inhibit pathological ECM remodeling to preserve cardiac output and prevent ventricular dilation. Understanding the complex crosstalk between these components is critical for developing regenerative therapies and improving long-term outcomes in patients with cardiac remodeling (Borg & Caulfield, 2002, Nature Reviews Molecular Cell Biology).

Other names
Cardiac microenvironmentCardiac extracellular matrix and immune nicheHeart stromal-immune systemCardiac matrisome
02

Mechanism of action

Modulation of the cardiac microenvironment through inhibition of the renin-angiotensin-aldosterone system (RAAS), reduction of pro-fibrotic signaling, and regulation of inflammatory cell infiltration to prevent maladaptive remodeling.

03

Biological functions

Tissue remodelingImmune responseStructural supportSignal transductionInflammationWound healing
04

Disease associations

Cardiovascular diseaseHeart failureMyocardial infarctionCardiac fibrosisInflammationHypertension
05

Safety considerations

Systemic immunosuppressionImpaired wound healing following acute injuryOff-target fibrosis in non-cardiac tissuesElectrolyte imbalancesHypotension
06

Interacting drugs

Sacubitril

5 more in the full profile.

07

Biomarkers

Galectin-3Soluble ST2Matrix metalloproteinase-9 (MMP-9)N-terminal pro-B-type natriuretic peptide (NT-proBNP)Procollagen type III amino-terminal peptide (PIIINP)

Beyond the preview

Go deeper on Multiple extracellular matrix components and immune cells in cardiac tissue.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Multiple extracellular matrix components and immune cells in cardiac tissue.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call